Pediatric oncology research in low income countries: Ethical concepts and challenges

Pediatric Blood and Cancer

Volumn 58, Issue 4, 2012, Pages 492-497

  Denburg, Avram E ^a   Joffe, Steven ^b   Gupta, Sumit ^a   Howard, Scott C ^c   Ribeiro, Raul C ^c   Antillon, Federico A ^d   Vasquez, Roberto ^e   Sung, Lillian ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d Unidad Nacional de Oncologia Pediatrica   (Guatemala)

^e Benjamin Bloom National Children's Hospital   (El Salvador)

Author keywords

Ethics review; Informed consent; Low income countries; Pediatric oncology; Research ethics; Standard of care; Trial benefits

Indexed keywords

CANCER RESEARCH; CHILDHOOD CANCER; HEALTH CARE QUALITY; HUMAN; INFORMED CONSENT; INSURANCE; LOWEST INCOME GROUP; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROFESSIONAL STANDARDS REVIEW ORGANIZATION; RESEARCH ETHICS; REVIEW;

BIOETHICS; BIOMEDICAL RESEARCH; CHILD; CHILD, PRESCHOOL; DEVELOPING COUNTRIES; FEMALE; HUMANS; MALE; MEDICAL ONCOLOGY;

EID: 84863145002     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.23419     Document Type: Review

References (45)

1. Ellison LF, Pogany L, Mery LS. Childhood and adolescent cancer survival: A period analysis of data from the Canadian Cancer Registry. Eur J Cancer 2007; 43: 1967-1975.
2. Ribeiro RC, Steliarova-Foucher E, Magrath I, et al. Baseline status of paediatric oncology care in ten low-income or mid-income countries receiving My Child Matters support: A descriptive study. Lancet Oncol 2008; 9: 721-729.
3. Kellie SJ, Howard SC. Global child health priorities: What role for paediatric oncologists? Eur J Cancer 2008; 44: 2388-2396.
4. Antillon F, Baez FL, Barr R, et al. AMOR: A proposed cooperative effort to improve outcomes of childhood cancer in Central America. Pediatr Blood Cancer 2005; 45: 107-110.
5. Harif M, Barsaoui S, Benchekroun S, et al. Treatment of B-cell lymphoma with LMB modified protocols in Africa-Report of the French-African Pediatric Oncology Group (GFAOP). Pediatr Blood Cancer 2008; 50: 1138-1142.
6. Howard SC, Marinoni M, Castillo L, et al. Improving outcomes for children with cancer in low-income countries in Latin America: A report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)-Part I. Pediatr Blood Cancer 2007; 48: 364-369.
7. Mostert S, Sitaresmi MN, Gundy CM, et al. Influence of socioeconomic status on childhood acute lymphoblastic leukemia treatment in Indonesia. Pediatrics 2006; 118: e1600-e1606.
8. Farmer P, Frenk J, Knaul FM, et al. Expansion of cancer care and control in countries of low and middle income: A call to action. Lancet 2010; 376: 1186-1193.
9. Howard SC, Pedrosa M, Lins M, et al. Establishment of a pediatric oncology program and outcomes of childhood acute lymphoblastic leukemia in a resource-poor area. JAMA 2004; 291: 2471-2475.
10. Ribeiro R, Pui CH. Treatment of acute lymphoblastic leukemia in low- and middle-income countries: Challenges and opportunities. Leuk Lymphoma 2008; 49: 373-376.
11. Sloan FA, Gelband H, editors. Cancer control opportunities in low- and middle-income countries. Washington: The National Academies Press; 2007.
12. The World Bank. Data Catalog: Country Classifications. Accessed.
13. Angell M. The ethics of clinical research in the Third World. N Engl J Med 1997; 337: 847-849.
14. Lurie P, Wolfe SM. Unethical trials of interventions to reduce perinatal transmission of the human immunodeficiency virus in developing countries. N Engl J Med 1997; 337: 853-856.
15. Macklin R. After Helsinki: Unresolved issues in international research. Kennedy Inst Ethics J 2001; 11: 17-36.
16. Shapiro HT, Meslin EM. Ethical issues in the design and conduct of clinical trials in developing countries. N Engl J Med 2001; 345: 139-142.
17. Wendler D, Emanuel EJ, Lie RK. The standard of care debate: Can research in developing countries be both ethical and responsive to those countries' health needs? Am J Public Health 2004; 94: 923-928.
18. Wertheimer A. Exploitation. Princeton, NJ: Princeton University Press; 1999.
19. US NBAC. 2001. Ethical and Policy Issues in International Research: Clinical Trials in Developing Countries. In US National Bioethics Advisory Commission [Online] Accessed.
20. Angell M. Investigators' responsibilities for human subjects in developing countries. N Engl J Med 2000; 342: 967-969.
21. Brennan TA. Proposed revisions to the declaration of Helsinki-Will they weaken the ethical principles underlying human research? N Engl J Med 1999; 341: 527-531.
22. Rothman KJ, Michels KB. The continuing unethical use of placebo controls. N Engl J Med 1994; 331: 394-398.
23. World Medical Association (WMA). 2008 [1964]. Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. WHA [Online]. Accessed.
24. Council for International Organizations of Medical Sciences (CIOMS). 2002. International Ethical Guidelines for Biomedical Research Involving Human Subjects. In Geneva: CIOMS [Online] Accessed.
25. Benatar SR, Singer PA. A new look at international research ethics. BMJ 2000; 321: 824-826.
26. Levine RJ. The "best proven therapeutic method" standard in clinical trials in technologically developing countries. IRB 1998; 20: 5-9.
27. Resnik DB. The ethics of HIV research in developing nations. Bioethics 1998; 12: 286-306.
28. Takala T. What is wrong with global bioethics? On the limitations of the four principles approach. Camb Q Healthc Ethics 2001; 10: 72-77.
29. UK Nuffield Council on Bioethics. The Ethics of Research Related to Healthcare in Developing Countries. London, UK: Nuffield Council on Bioethics; 2002.
30. Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA 2000; 283: 2701-2711.
31. Arras JD. Fair benefits in international medical research. Hastings Cent Rep 2004; 34: 3-4.
32. Glantz LH, Annas GJ, Grodin MA, et al. Research in developing countries: Taking "benefit" seriously. Hastings Cent Rep 1998; 28: 38-42.
33. Zong Z. Should post-trial provision of beneficial experimental interventions be mandatory in developing countries? J Med Ethics 2008; 34: 188-192.
34. Benatar SR. Reflections and recommendations on research ethics in developing countries. Soc Sci Med 2002; 54: 1131-1141.
35. Mari JJ, Lozano JM, Duley L. Erasing the global divide in health research. BMJ 1997; 314: 390-391.
36. Lavery JV. Putting international research ethics guidelines to work for the benefit of developing countries. Yale J Health Policy Law Ethics 2004; 4: 319-336.
37. Moral standards for research in developing countries: From "reasonable availability" to "fair benefits". Hastings Cent Rep 2004; 34: 17-27.
38. Caniza MA, Clara W, Maron G, et al. Establishment of ethical oversight of human research in El Salvador: Lessons learned. Lancet Oncol 2006; 7: 1027-1033.
39. Moodley K, Myer L. Health Research Ethics Committees in South Africa 12 years into democracy. BMC Med Ethics 2007; 8: 1-8.
40. Emanuel EJ, Steiner D. Institutional conflict of interest. N Engl J Med 1995; 332: 262-267.
41. Weijer C, Emanuel EJ. Ethics. Protecting communities in biomedical research. Science 2000; 289: 1142-1144.
42. Ford N, Mills EJ, Zachariah R, et al. Ethics of conducting research in conflict settings. Confl Health 2009; 3: 7-28.
43. Schopper D, Upshur R, Matthys F, et al. Research ethics review in humanitarian contexts: The experience of the independent ethics review board of Medecins Sans Frontieres. PLoS Med 2009; 6: e1000115.
44. UNESCO. 2005. Universal Declaration on Bioethics and Human Rights. In United Nations Educational, Scientific and Cultural Organization [Online] Accessed.
45. Indian Council for Medical Research. Ethical Guidelines for Biomedical Research on Human Subjects. New Delhi: ICMR; 2006.